By increasing the RANKL/OPG ratio, irrespective of the presence of estrogen, GnRH and kisspeptin may thus disrupt bone remodeling homeostasis to favor osteoclastic activity, which may further accelerate the growth and spread of osteosarcoma. The gene discussed is TNFRSF11B; the disease is osteosarcoma.